» Articles » PMID: 18439091

Does TAL-1 Deletion Contribute to the High Incidence of T-cell Acute Lymphoblastic Leukemia in South Indian Patients?

Overview
Specialty Oncology
Date 2008 Apr 29
PMID 18439091
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of T-cell acute lymphoblastic leukemia (T-ALL) in South India is very high (43.1%) when compared to the Western countries (10-20%). TAL-1 deletion is the most common genetic abnormality in T-ALL.

Objectives: The present study was aimed to detect the incidence of type 1 and type 2 TAL-1 deletions and assess whether they might contribute to the high incidence of T-ALL in South India.

Materials And Methods: 45 cases of T-ALL (pediatric-32, adolescents-7 and young adults-6) were studied by DNA-PCR and sequencing. Age of the patients ranged from 3 yrs to 29 yrs (median age 14 yrs).

Results: TAL-1 deletion type 1 was detected in 6 (13.3%) cases (3 pediatric and 3 adolescents) and all were males. TAL-1 deletion type 2 was not present. Comparing the clinical features and immunological marker analysis of TAL-1 deletion positive and negative cases did not show any significant differences except in the WBC count, which was significantly higher in cases showing TAL-1 deletion (>100 x 109/L, p value= 0.003). All the positive cases of TAL-1 deletion were confirmed by sequencing, the results showing that the fusion region at SIL gene and TAL-1 gene contained an average 'N region' insertion of 7.8 nucleotides. The numbers of nucleotides deleted at the 5' end and 3' end of TAL-1 gene were averages of 3 and 1, respectively.

Conclusion: Though the incidence of T-ALL is high in South India, the frequency of TAL-1 deletion and their fusion gene sequences are not unique and are similar to those reported in other ethnic and geographic populations. Hence the present study indicates that TAL-1 deletion alone does not contribute to the high incidence of T-ALL in South Indian patients.

Citing Articles

Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).

Ardalan N, Sepahi A, Ali Khavari-Nejad R Asian Pac J Cancer Prev. 2021; 22(4):1137-1147.

PMID: 33906306 PMC: 8325130. DOI: 10.31557/APJCP.2021.22.4.1137.


Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.

Mroczek A, Zawitkowska J, Kowalczyk J, Lejman M Int J Mol Sci. 2021; 22(2).

PMID: 33467425 PMC: 7829804. DOI: 10.3390/ijms22020808.


Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India.

Manipadam M, Nair S, Viswabandya A, Mathew L, Srivastava A, Chandy M World J Pediatr. 2011; 7(4):318-25.

PMID: 21633853 DOI: 10.1007/s12519-011-0303-7.